IPH-3201

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIPH-3201
Drug Alias NameTLR-7 modulators (Innate)TLR-7 modulators (Cancer Research Technology)Toll-like receptor 7 modulators (Innate)IPH-3201
ClassificationBiologics
Mechanisms of ActionToll like receptor 7 modulators
TargetsToll like receptor 7
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Research TechnologyInnate Pharma
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A